21 – 30 of 125
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
The Cost-effectiveness of Biological Therapy Cycles in the Management of Crohn's Disease
(
- Contribution to journal › Article
-
Mark
Liver cirrhosis in southern Sweden. Epidemiology and clinical course.
(
- Thesis › Doctoral thesis (compilation)
-
Mark
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis
(
- Contribution to journal › Article
-
Mark
Risk and outcome of hepatocellular carcinoma in liver cirrhosis in Southern Sweden : a population-based study
(
- Contribution to journal › Article
-
Mark
Är ägg bra vid typ 2 diabetes, fetma och fettlever?
2019)(
- Other contribution › Web publication
-
Mark
Kolinfosfolipider, en nyttig kostkomponent vid alkoholfettler, NAFLD och NASH
2019)(
- Contribution to conference › Poster
- 2018
-
Mark
Deficiency of alkaline SMase enhances dextran sulfate sodium-induced colitis in mice with upregulation of autotaxin
(
- Contribution to journal › Article
-
Mark
Effects of Vedolizumab Therapy on Extraintestinal Manifestations in Inflammatory Bowel Disease
(
- Contribution to journal › Article
-
Mark
Alkaline sphingomyelinase (NPP7) in hepatobiliary diseases : A field that needs to be closely studied
(
- Contribution to journal › Scientific review
-
Mark
Patients with liver cirrhosis show worse survival if decompensation occurs later during course of disease than at diagnosis
(
- Contribution to journal › Article